Simulated mean steady-state pharmacokinetic and pharmacodynamic profiles supported a flat and stable IDeg exposure and effect regardless of injection region , with comparable total glucose-lowering effects [ area under the GIR curve at steady state ( AUCGIR , , SS ) ] between the thigh , abdomen and deltoid .